CBI's Patent Strategy & Portfolio Planning for Life Sciences Congress

On Tuesday, December 8, 2015, Fish's Dorothy Whelan (Twin Cities) is a moderator on "The Intersection of IPR & Hatch-Waxman Litigation" at CBI's Patent Strategy & Portfolio Planning for Life Sciences conference in Philadelphia, PA.

Joining Dorothy on the panel is Bruce A. Pokras, Senior Corporate Counsel at Pfizer, and Paul Simboli, Vice President and Chief Patent Counsel, Assistant General Counsel at Depomed.

This conference is designed exclusively for intellectual property/patent counsel at brand and generic pharma/biotech companies and life sciences patent lawyers. Featured topics include:

• Patent Legislative Reform Update
• IPRs
• Biosimilars Legal Update
• 2015s First Wave of Life Sciences IPRs
• PTO Patent Trial Best Practices
• Due Diligence Strategies
• Impact on Deal-Making and Collaborations
• Lessons Learned from the Latest BPCIA Cases